Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
ASA Clinical Research, LLC
mi
from
Jupiter, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
ASA Clinical Research, LLC
mi
from
Jupiter, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
South Florida Research Institute
mi
from
Citrus Park-Fern Lake, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
South Florida Research Institute
mi
from
Citrus Park-Fern Lake, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology Associates of South Miami
mi
from
Miami, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology Associates of South Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Suncoast Clinical Research
mi
from
Palm Harbor, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Suncoast Clinical Research
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Discovery Medical Research Group
mi
from
Ocala, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Discovery Medical Research Group
mi
from
Ocala, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology Associates of Central Florida, PA
mi
from
Orlando, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology Associates of Central Florida, PA
mi
from
Orlando, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology Associates of Central Florida PA
mi
from
Orlando, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology Associates of Central Florida PA
mi
from
Orlando, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Pembroke Clinical Trials
mi
from
Pembroke Pines, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Pembroke Clinical Trials
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Coastal Nephrology Associates Research Center, LLC
mi
from
Port Charlotte, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Coastal Nephrology Associates Research Center, LLC
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Metabolic Research Institute
mi
from
West Palm Beach, FL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Metabolic Research Institute
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Emory University
mi
from
Atlanta, GA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Kidney Care Associates, LLC
mi
from
Augusta, GA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Kidney Care Associates, LLC
mi
from
Augusta, GA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Canton Kidney Center
mi
from
Canton, GA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Canton Kidney Center
mi
from
Canton, GA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Atlanta Nephrology Referral Center
mi
from
Decatur, GA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Atlanta Nephrology Referral Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Renal Physicians of Georgia
mi
from
Macon, GA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Renal Physicians of Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Kaiser Foundation Health Plan of Georgia, Inc
mi
from
Tucker, GA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Kaiser Foundation Health Plan of Georgia, Inc
mi
from
Tucker, GA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
East-West Medical Research Institute
mi
from
Honolulu, HI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
East-West Medical Research Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
UH Diabetes and Endocrinology
mi
from
Honolulu, HI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
UH Diabetes and Endocrinology
mi
from
Honolulu, HI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Pacific Renal Research Institute
mi
from
Caldwell, ID
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Pacific Renal Research Institute
mi
from
Caldwell, ID
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Apex Clinical Research
mi
from
Chicago, IL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Apex Clinical Research
mi
from
Chicago, IL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
NorthShore University HealthSystem
mi
from
Evanston, IL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Research by Design
mi
from
Evergreen Park, IL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Research by Design
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
North Suburban Nephrology, LLC
mi
from
Gurnee, IL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
North Suburban Nephrology, LLC
mi
from
Gurnee, IL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Edward Hines,Jr., VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Renal Care Associates
mi
from
Peoria, IL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Renal Care Associates
mi
from
Peoria, IL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology Physicians, PA
mi
from
Shawnee Mission, KA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology Physicians, PA
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Cotton-O'Neal Clinical Research Center
mi
from
Topeka, KA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Cotton-O'Neal Clinical Research Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Kansas Nephrology Research Institute, LLC
mi
from
Wichita, KA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Kansas Nephrology Research Institute, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
University of Louisville - Kidney Disease Program
mi
from
Louisville, KY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
University of Louisville - Kidney Disease Program
mi
from
Louisville, KY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Four Rivers Clinical Research
mi
from
Paducah, KY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Four Rivers Clinical Research
mi
from
Paducah, KY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Louisiana State University Health Sciences Center
mi
from
Shreveport, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Louisiana State University Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Tulane Medical Center
mi
from
New Orleans, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Tulane Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Green Clinic LLC
mi
from
Ruston, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Green Clinic LLC
mi
from
Ruston, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Maine Nephrology Associates
mi
from
Portland, ME
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Maine Nephrology Associates
mi
from
Portland, ME
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Anne Arundel Medical Center
mi
from
Annapolis, MD
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Anne Arundel Medical Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
A. Kaldun Nossuli
mi
from
Bethesda, MD
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
A. Kaldun Nossuli
mi
from
Bethesda, MD
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Biolab Research, LLC
mi
from
Rockville, MD
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Biolab Research, LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Western New England Renal & Transplant Associates, PC
mi
from
Springfield, MA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Western New England Renal & Transplant Associates, PC
mi
from
Springfield, MA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Fallon Clinic, Division of Renal Medicine
mi
from
Worchester, MA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Fallon Clinic, Division of Renal Medicine
mi
from
Worchester, MA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Alzohaili Medical Consultants
mi
from
Dearborn, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Alzohaili Medical Consultants
mi
from
Dearborn, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
St. Clair Specialty Physicians
mi
from
Detroit, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
St. Clair Specialty Physicians
mi
from
Detroit, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Henry Ford Hospital
mi
from
Detroit, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Apex Medical Research
mi
from
Flint, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Apex Medical Research
mi
from
Flint, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Hurley Medical Center
mi
from
Flint, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Troy Internal Medicine, PC, Research Department
mi
from
Troy, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Troy Internal Medicine, PC, Research Department
mi
from
Troy, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Twin Cities Clinical Research
mi
from
Brooklyn Center, MN
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Twin Cities Clinical Research
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials